Memorial Sloan-Kettering Cancer Centre

New York, New York 10065

3 studies enrolling now · 9 studies all time

What they study most

Advanced Solid Tumors, Bladder Neoplasms, Germ Cell Tumor, Multiple Myeloma, Multiple Myeloma Progression, Multiple Myeloma With Failed Remission, Multiple Myeloma in Relapse, Myxoid Liposarcoma, Ovarian Cancer, Sarcoma, Soft Tissue Sarcoma, Synovial Sarcoma

Studies at this site

• A Clinical Study to Investigate the Efficacy of Intratumoral Tigilanol Tiglate in Soft Tissue Sarcoma — Recruiting now
• Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours — Recruiting now
• Expanded Access Protocol (EAP) for Nonconforming (NC) Afami-cel — Available (expanded access)
• Effect of AT7519M Alone and AT7519M Plus Bortezomib in Patients With Previously Treated Multiple Myeloma — Completed
• A Phase I Trial to Assess the Effects of Food and Formulation on PK of KPT-330 in Patients With Sarcoma — Completed
• Tinostamustine Conditioning and Autologous Stem Cell — Stopped early
• Mycobacterial Cell Wall-DNA Complex in Treatment of BCG-refractory Patients With Non-muscle Invasive Bladder Cancer — Completed
• Efficacy Multicentre Trial of ImmunoTherapy Vaccination With Abagovomab to Treat Ovarian Cancer Patients — Stopped early
• Phase I Study of U3P1287/01, Including Patients With Advanced Solid Tumors — Completed